1. Home
  2. RMTI vs HOWL Comparison

RMTI vs HOWL Comparison

Compare RMTI & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rockwell Medical Inc.

RMTI

Rockwell Medical Inc.

HOLD

Current Price

$0.72

Market Cap

32.9M

Sector

Health Care

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.48

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMTI
HOWL
Founded
1994
2017
Country
United States
United States
Employees
300
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.9M
30.7M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
RMTI
HOWL
Price
$0.72
$0.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$2.00
$5.00
AVG Volume (30 Days)
273.7K
641.9K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
$69,258,000.00
N/A
Revenue This Year
$8.64
N/A
Revenue Next Year
$8.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.40
52 Week High
$2.10
$2.23

Technical Indicators

Market Signals
Indicator
RMTI
HOWL
Relative Strength Index (RSI) 30.47 36.72
Support Level N/A $0.40
Resistance Level $1.02 $0.76
Average True Range (ATR) 0.04 0.05
MACD -0.00 0.00
Stochastic Oscillator 3.65 26.74

Price Performance

Historical Comparison
RMTI
HOWL

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: